To visually distinguish the phenotype of M2 macrophages, the expression of CD163, a marker of M2 TAMs, was examined by immunohistochemistry (IHC) in a commercial human breast cancer tissue array containing 139 tumor sections. This evidence concerns the gene CD163 and neoplasm.